##gff-version 3
##sequence-region Q92917 1 476
Q92917	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
Q92917	UniProtKB	Chain	2	476	.	.	.	ID=PRO_0000087559;Note=G-patch domain and KOW motifs-containing protein	
Q92917	UniProtKB	Domain	164	210	.	.	.	Note=G-patch;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00092	
Q92917	UniProtKB	Domain	240	267	.	.	.	Note=KOW 1	
Q92917	UniProtKB	Domain	415	442	.	.	.	Note=KOW 2	
Q92917	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:22814378;Dbxref=PMID:22814378	
Q92917	UniProtKB	Modified residue	27	27	.	.	.	Note=Phosphoserine%3B by PKA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21880142;Dbxref=PMID:21880142	
Q92917	UniProtKB	Modified residue	35	35	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q92917	UniProtKB	Modified residue	42	42	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:23186163	
Q92917	UniProtKB	Modified residue	115	115	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q92917	UniProtKB	Modified residue	216	216	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:24275569;Dbxref=PMID:18669648,PMID:19690332,PMID:20068231,PMID:24275569	
Q92917	UniProtKB	Modified residue	316	316	.	.	.	Note=Phosphothreonine%3B by PKA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21880142;Dbxref=PMID:21880142	
Q92917	UniProtKB	Modified residue	471	471	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q92917	UniProtKB	Modified residue	473	473	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q92917	UniProtKB	Cross-link	5	5	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q92917	UniProtKB	Mutagenesis	27	27	.	.	.	Note=Reduced phosphorylation. Significant loss of phosphorylation and increased RNA-binding%3B when associated with A-316. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21880142;Dbxref=PMID:21880142	
Q92917	UniProtKB	Mutagenesis	176	177	.	.	.	Note=Significant loss of interaction with DHX16. No loss of pre-mRNA splicing activity. Able to suppress the splicing defect observed in dominant-negative DHX16 mutant expressing cells. GW->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25296192;Dbxref=PMID:25296192	
Q92917	UniProtKB	Mutagenesis	259	260	.	.	.	Note=No loss of interaction with DHX16. Reduced pre-mRNA splicing activity. Decreased ability to suppress the splicing defect observed in dominant-negative DHX16 mutant expressing cells. GK->AA;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25296192;Dbxref=PMID:25296192	
Q92917	UniProtKB	Mutagenesis	316	316	.	.	.	Note=Reduced phosphorylation. Significant loss of phosphorylation and increased RNA-binding%3B when associated with A-27. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21880142;Dbxref=PMID:21880142	
Q92917	UniProtKB	Sequence conflict	317	317	.	.	.	Note=L->F;Ontology_term=ECO:0000305;evidence=ECO:0000305	
